ICON Central Laboratories Doubles Biospecimen Storage Capacity
News Nov 16, 2012
ICON plc has announced that it has expanded the biorepository capacity in its Central Laboratory located in Farmingdale, New York.
The expansion doubles ICON’s sample storage capacity globally and supports the long term sample storage needs of clinical trials.
“We’re investing in this expansion to meet our sponsor’s biorepository needs and because we believe that long-term preservation of samples is essential for the future of drug development, in particular for personalized medicine strategies that foresee an ever-increasing need for downstream analysis,” commented Tom O’Leary, President, ICON Central Laboratories.
Tom O’Leary continued, “The co-location of our biorepository services with our central labs in North America, Europe, Singapore and India is critical, as it allows for future analysis while minimizing the risks and costs associated with transporting samples.”
ICON’s global biorepository facilities store a wide-range of specimens, including plasma, serum, whole blood, RNA, DNA, peripheral blood mononuclear cell (PBMC), urine and tissue at frozen storage conditions of -20°C, -70°C, -80°C, and -150°C liquid nitrogen.
This latest expansion provides additional capacity to ICON’s existing end-to-end biospecimen management solution, which ensures sample integrity and full chain of custody across the entire lifecycle from collection and processing to final disposal.
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE
Sartorius Stedim Biotech and Siemens Sign Automation AgreementNews
Siemens becomes a preferred supplier for automation solutions. Product portfolio of Sartorius Stedim Biotech to feature a globally standardized automation platform in the future.READ MORE
Cocaine Use Alters Gene Expression in Brain Reward CircuitsNews
A study in Biological Psychiatry investigates transcriptome-wide alterations in response to cocaine self-administration in mice.